The present invention relates generally to the field of medical devices to be used for cardiological procedures. More specifically, the invention is in the subfield of catheterization devices and other tools to be used for cardiac ablation and in electrophysiological procedures.
Cardiac arrhythmias are a widespread medical condition facing physicians today. Their most frequent cause is an abnormal routing of electricity though the cardiac tissue. While several surgical approaches have been developed for the purpose of treating or preventing different types of cardiac arrhythmias, ablation is now widely used as the preferred treatment. Typically, a physician places an endocardial catheter with an electrode at its tip inside the heart at a location where cells are giving off abnormal electrical signals. The electrode is activated according to various known modes of operation such that the adjacent targeted tissue is ablated and rendered non-conductive, halting the spread of improper cardiac signals.
The arrhythmia substrate is often deep in the wall of the heart, or transmural. Thus, the clinician performing the ablation wants the input energy and resulting heat to propagate entirely through the endocardium to the epicardium, thus thoroughly lesioning the substrate in question. However, critical structures lie directly outside the epicardium, and the fundamental conflict is one of depositing energy deep within the heart tissue on the one hand, but not damaging tissues, organs and structures beyond the heart wall, on the other. As an example, on average the esophagus in only 2 mm from the atrial epicardium yet the atrial is 3 mm thick. Therefore, ablationists essentially want to burn deep enough, but not too deep.
Although simple ablations are performed with relatively few complications, some of the more complex ablations that have been developed recently use more energy over longer periods of time. For example, whereas the standard ablation for atrioventricular nodal reentry requires only 60 seconds of burning, a standard ablation for atrial fibrillation (AF) may require 4000 seconds of burning. Furthermore, whereas traditional ablations are often done on the inner walls of the heart, the more complex ablations are often performed on the heart's free wall, which is even closer to the lungs, phrenic nerve, and esophagus. Recent case reports have shown complications and even death from burns that damage these structures after an AF ablation.
Modern radio frequency ablation catheter procedures operate by delivering current between a small (2-8 mm) anode located in the tip of a standard ablation catheter coupled to a large surface area conductive cathode provided on the patient's back. Current flowing between the anode and the cathode is at its highest density at the tissue location directly adjacent to the treatment electrode. Thus, a planar sheet of the current flow can be modeled as a triangle with its apex at the ablation tip (anode) and its base on the patient's back (cathode). Though most of the burning is close to the apex of the triangle, the esophagus, lungs, and phrenic nerve are within the current density triangle. The current does not drop off sufficiently between the epicardium and the adjacent structures due to the inherent proximity.
There is therefore a need in the art for an effective electrode catheter that could be electrically coupled to an endocardial or other type of ablation catheter to provide better and safer modes of treatment. Particular needs remain for such a device with appropriate length, diameter, stabilization, steering capacity, and irrigation to allow effective energy transfers transmurally through the endocardial wall.
To overcome these limitations, we have conceived the subject device and method of use, as described in the Summary of the Invention and Detailed Description of the Drawings below.
Because ablation lesions must be created such that electrical conductivity is halted in the localized region, it is desirable to have a cathode as close to the anode as possible. The use of two standard endocardial catheters to carry out a procedure wherein one of them served as an epicardial cathode would cause several limiting considerations that would arise from such a practice. Most generally, an endocardial catheter is simply not designed for the mechanics of epicardial use. In particular, special issues regarding device length, diameter, stabilization, and steering capabilities have to be taken into account. Furthermore, the use of two standard endocardial catheters would mean that the anode and cathode would have the same size. Generally, the cathode should present a larger surface area towards the endocardial anode so that there is more current density near the anode. Lastly, the standard endocardial catheter is not able to provide a flow of irrigation fluid that could be used to cool the electrode or to separate the epicardial surface from critical neighboring anatomical structures.
The following U.S. patent documents discuss epicardial electrodes in the context of pacing: U.S. Pat. Nos. 7,085,606; 6,266,567; 5,509,924; 5,300,110; 4,971,070; 4,817,634; and 4,607,644; as well as U.S. Statutory Invention Registration H356, all of which are incorporated by reference herein in their entirety. No references disclose epicardial electrodes in the context of ablation or eletrophysiological procedures.
One aspect of the present invention provides an electrode catheter disposed in the middle mediastinum of the thorax of a subject for use in ablation procedures with an endocardial ablation catheter. The electrode catheter may comprise a proximal portion, a distal portion, and a longitudinal structure there between. In accordance with the invention, the electrode catheter may further include an electrode adapted for receiving energy from the endocardial ablation catheter.
Another aspect of the present invention provides an electrode catheter disposed in the intra-cardiac space of a subject for use in ablation procedures with an epicardial ablation catheter. The electrode catheter may comprise a proximal portion, a distal portion, and a longitudinal structure there between. In accordance with the invention, the electrode catheter may further include an electrode adapted for receiving energy from the epicardial ablation catheter.
Yet another aspect of the present invention relates to a method of ablating a portion of the heart by disposing an electrode in the middle mediastinum of the thorax of a subject and receiving transmitted energy from an endocardial ablation catheter.
Further yet, another aspect of the present invention relates to a method of ablating a portion of the heart by disposing an electrode in the intra-cardiac space of a subject and receiving transmitted energy from an epicardial ablation catheter.
It should be appreciated that the present invention cardiac catheter may be place or disposed in, adjacent or proximal to any space, structure, blood vessel, vasculature or organ.
An aspect of an embodiment of the present invention comprises a method for use with an endocardial ablation catheter, which transmits energy for ablating a portion of a heart. The method may comprise: disposing an electrode in the middle mediastinum of the thorax of a subject; and receiving the transmitted energy from the endocardial ablation catheter. The middle mediastinum may include, for example, an area outside the pericardium, an area inside the pericardium, or the pericardium space itself.
An aspect of an embodiment of the present invention comprises a method for use with an epicardial ablation catheter, which transmits energy for ablating a portion of a heart. The method may comprise: disposing an electrode in the intra-cardiac space of a subject; and receiving the transmitted energy from the epicardial ablation catheter.
Advantageously, upon activation of the electrode catheter and endocardial or other type of ablation catheter, energy from the ablation catheter is transmitted through the heart wall and is received by the electrode catheter. In this way, a triangular-shaped current density pattern is formed between the endocardial or other type of ablation catheter and the electrode of the electrode catheter. Tissue within this current flow is ablated, while proximal organs are left undamaged by the ablation energy. In older methods a large electrode is placed on or in contact with the patient's back, allowing ablation energy to reach not only the heart-wall tissue, but to travel through other proximal vital organs.
The invention itself, together with further objects and attendant advantages, will best be understood by reference to the following detailed description taken in conjunction with the accompanying drawings.
The foregoing and other objects, features and advantages of the present invention, as well as the invention itself, will be more fully understood from the following description of preferred embodiments, when read together with the accompanying drawings in which:
The following detailed description is of the best presently contemplated modes of carrying out the invention. This description is not to be taken in a limiting sense, but is made merely for the purpose of illustrating general principles of embodiments of the invention.
The proximal portion 40 of the catheter 6 may be implemented as desired or required along any point or segment, for example, as illustrated by the bracket in
The electrode catheter 6 may further comprises a distal fluid aperture, 2, located at the distal portion 45, a proximal fluid aperture 7 located at the proximal portion 40, and a fluid lumen 22, 23 (as shown in
The catheter 6 further comprises a distal steering means 4 and a proximal steering means 5 which have the steering characteristics taught by Mahapatra et al. in PCT International Application No. Serial No. PCT/US2008/056816, filed Mar. 13, 2008, entitled, “Epicardial Ablation Catheter and Method of Use,” hereby incorporated by reference herein in its entirety. The steering means may be guide wires, tensioning lines, pull strings, digitating distal tips, magnetic guidance means, wires, rods, chains, bands, chords, ropes, string tubes, filaments, threads, fibers, stands, other extended elements, or any other method known in the art. At the proximal end of the catheter may be a control handle 8, which may have integral to it the distal steering control means 9, the proximal steering control means 10, and the control means for the stabilization means 14. The handle is preferably sized to be grasped, held and operated by a user. It should be appreciated that other control and operating interface members, devices or means may be utilized for the handle. Attached to the proximal end of the control handle is the handle proximal port 11, which has a second fluid aperture 13, and from which the electrical lead 12 for the electrode 3 extends, in order to make electrical connections. Wire(s) (shown in
For instance, referring to
Moreover, for instance and referring to
It should be appreciated that the medium to flow through ablation catheter device or system may be at least one of the following: agent, substance, material, saline solutions, thrombolytic agents, clot lysis agents, chemotherapies, cell slurries, gene therapy vectors, growth factors, contrast agents, angiogenesis factors, radionuclide slurries, anti-infection agents, anti-tumor compounds, receptor-bound agents and/or other types of drugs, therapeutic agent and/or diagnostic agent, or any combination thereof.
It should be appreciated that any of the components or modules referred to with regards to any of the present invention embodiments discussed herein, may be integrally or separately formed with one another. Further, redundant functions or structures of the components or modules may be implemented. Moreover, the various components may be communicated locally and/or remotely with any user/clinician/patient or machine/system/computer/processor. Moreover, the various components may be in communication via wireless and/or hardwire or other desirable and available communication means, systems and hardware.
Moreover, it should be appreciated that any of the components or modules referred to with regards to any of the present invention embodiments discussed herein, may be a variety of materials and/or composites as necessary or required. Still further, it should be appreciated that any of the components or modules (or combination thereof) may provide shape, size and volume contoured by adjusting its geometry and flexibility/rigidity according to the target location or anatomy (or region, including structure and morphology of any location) being treated.
Further, it should be appreciated that the present invention ablation system may be inserted into a subject via an interventional procedure or a surgical procedure, as well as a combination thereof.
It should be appreciated that the various sheaths, catheters and guidewires, or any related components disclosed herein, may have a circular or oval shaped cross-section or various combinations thereof. Further, it should be appreciated that various sheaths, catheters and guidewires, or any related components disclosed herein may have any variety of cross sections as desired or required for the medical procedure or anatomy.
For instance, but not limited thereto, the electrode catheter may be disposed in the middle mediastinum, any area outside the pericardium, or any area inside the pericardium.
Although not illustrated, an embodiment of the present invention provides an endocardial electrode catheter disposed in the intra-cardiac space of a subject for use in ablation procedures with an epicardial ablation catheter. In accordance with the invention, the electrode catheter further includes an electrode adapted for receiving energy from the epicardial ablation catheter. For example, but not limited thereto, the intra-cardiac space includes the left ventricle and/or right ventricle, as well as any interior region or region in proximity to the interior of the heart.
Although not illustrated, an embodiment of the present invention provides an electrode catheter disposed in the intra-cardiac space of a subject for use in ablation procedures with an endocardial ablation catheter. In accordance with the invention, the electrode catheter further includes an electrode adapted for receiving energy from the endocardial ablation catheter. For example, but not limited thereto, the endocardial cathode catheter may be disposed in the intra-cardiac space and the endocardial ablation catheter may be in a second intra-cardiac space. The intra-cardiac spaces may be various ventricles or chambers of the heart, or any desirable or required regions of the heart.
An aspect of an embodiment of the present invention ablation system may be implemented with an access needle (introducer needle), conduit or the like. The access needle or conduit is adapted to be inserted into the epicardial region or other body part or body space so as to provide an access or guideway for the present invention ablation catheter, sheath, guidewire, etc. An example of an access system is disclosed in PCT International Application No. Serial No. PCT/US2008/056643, filed Mar. 12, 2008, entitled, “Access Needle Pressure Sensor Device and Method of Use,” of which is hereby incorporated by reference herein in its entirety. See for example, but not limited thereto,
Although not shown, as mentioned above, the insertion of the electrode catheter into the epicardial region may be aided by the use of an access needle and subsequent passage of a guidewire. The access needle may first be inserted into the epicardium, with the guidewire then put in place. The electrode catheter may then be coaxially slid over the guidewire to access the epicardial region.
Although not shown and involving another approach, the insertion of a sheath into the epicardial region may be aided by the use of an access needle and subsequent passage of a guidewire. The access needle may first be inserted into the epicardium, with the guidewire then put in place. The sheath may then be coaxially slid over the guidewire to access the epicardial region. After positioning the sheath in the desired position, the catheter may then be inserted through the sheath to reach the epicardium.
For example, with present invention, an epicardial access needle-stick is may be implemented in the subxiphoid area of the chest and the catheter device must then only be advanced a short distance to get to the heart. However, it may immediately be steered through an acute angle to avoid the heart itself. Because of this, aspects of the present invention devices and those used in conventional techniques can be contrasted. For instance, conventional endocardial catheters may typically be 100 cm in length or longer since they must go from the leg to the heart, while an embodiment of the present invention electrode catheter could be, for example, about 30 cm or less since it may only need to go from the chest to the heart. It should be appreciated that the length may be greater than 30 cm as well. Similarly, catheters in excess of the required 30 cm could be an awkward physical obstacle that would interfere with the procedure and, if inadvertently bumped or moved, could injure the patient. Similarly the conventional long catheters used in cathode and ablation devices, while not dangerous as such, are nevertheless awkward. Another reason that present invention shorter catheters may be preferred in epicardial procedures is that it is easier to effect rotation of the distal end of a catheter through rotation of the proximal end if the length of the catheter is shorter. Therefore, a shorter sheath and catheter would be less awkward, easier to use, and safer.
It should be appreciated that various embodiments of the present invention electrode catheter may have a total length of less than about 200 cm, less than about 100, less than about 50 cm, less than about 25 cm, or less than about 20 cm, or may be shorter even yet if desired or required. It should be appreciated that the total length may be longer than any of the ranges provided above.
Although not shown, in another exemplary embodiment the electrode catheter 6 may be placed endocardially in order to receive transmitted energy from an epicardial ablation catheter or another endocardial ablation catheter.
It should be appreciated that as discussed herein, a subject may be a human or any animal. It should be appreciated that an animal may be a variety of any applicable type, including, but not limited thereto, mammal, veterinarian animal, livestock animal or pet type animal, etc. As an example, the animal may be a laboratory animal specifically selected to have certain characteristics similar to human (e.g. rat, dog, pig, monkey), etc. It should be appreciated that the subject may be any applicable human patient, for example.
One skilled in the art can see that many other embodiments of means and methods for using the electrode catheter in the ablation of cardiac tissues according to the technique of the invention, and other details of construction and use thereof, constitute non-inventive variations of the novel and insightful conceptual means, system and technique which underlie the present invention.
Practice of the invention will be still more fully understood from the following examples, which are presented herein for illustration only and should not be construed as limiting the invention in any way.
In a specific example embodiment, the overall length of the electrode catheter from the distal end to the proximal end is approximately 30 cm: 5 cm from the distal tip of the catheter to the distal steering point, 15 cm from the distal steering point to the proximal steering point, and 10 cm from the proximal steering point to the control handle or proximal fluid aperture. The electrode catheter is nominally 8 french in about 2.7 mm. The catheter further comprises a platinum cathode at the distal tip having a semi-cylindrical geometry (an arc of 180 degrees), a circumference of 5.7 mm (consistent with the 8 Fr size), and an axial length of 25 mm. Additionally, the catheter comprises two distal fluid apertures of different sizes, wherein the larger of the two apertures is used for suction of fluid and the smaller is used for emission of fluid, preventing tamponade. Further, the catheter is steerable at two points along its axial length. Finally, the catheter is able to deploy two side flaps or extensions that, when open, work to rotationally stabilize the catheter so that it can not flip over, thus providing confidence that only the desired side of the device would be facing the heart during heating or usage.
The following patents, applications and publications as listed below and throughout this document are hereby incorporated by reference in their entirety herein.
The devices, systems, compositions and methods of various embodiments of the invention disclosed herein may utilize aspects disclosed in the following references, applications, publications and patents and which are hereby incorporated by reference herein in their entirety:
A. d'Avila et al., “Transthoracic Epicardial Catheter Ablation of Ventricular Tachycardia,” Heart Rhythm, Vol. 3, pp. 1110-1111, (2006).
E. Sosa et al., “Epicardial Mapping and Ablation Techniques to Control Ventricular Tachycardia,” Journal of Cardiovascular Electrophysiology, Vol. 16, pp. 449-452, (2005).
S. Mahapatra et al., “Incidence and Predictors of Cardiac Perforation after permanent Pacemaker Placement,” Heart Rhythm, Vol. 2, pp. 907-911, (2005).
D. L. Packer et al., “Multimodality 3-D Ultrasound and Computed Tomographic Image Fusion: A Novel Basis for Catheter Navigation and Electroanatomic Mapping,” Circulation, Vol. 112, p. U684, (2005).
E. Sosa et al., “Nonsurgical Transthoracic Epicardial Approach in Patients with Ventricular Tachycardia and Previous Cardiac Surgery,” Journal of Interventional Cardiac Electrophysiology, Vol. 10, pp. 281-288, (2004).
W. P. Beukema et al., “Radiofrequency Ablation of Atrial Fibrillation in Patients Undergoing Concommitant Cardiac Surgery. First Experience,” PACE, Vol. 20 (Part II), p. 1100, (Apr. 1997).
L. S. Klein et al., “Radiofrequency Ablation of Cardiac Arrhythmias,” Scientific American Science & Medicine, pp. 48-57, (May/Jun. 1994).
The invention may be embodied in other specific forms without departing from the spirit or essential characteristics thereof. The foregoing embodiments are therefore to be considered in all respects illustrative rather than limiting of the invention described herein. Scope of the invention is thus indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced herein.
In summary, while the present invention has been described with respect to specific embodiments, many modifications, variations, alterations, substitutions, and equivalents will be apparent to those skilled in the art. The present invention is not to be limited in scope by the specific embodiment described herein. Indeed, various modifications of the present invention, in addition to those described herein, will be apparent to those of skill in the art from the foregoing description and accompanying drawings. Accordingly, the invention is to be considered as limited only by the spirit and scope of the following claims, including all modifications and equivalents.
Still other embodiments will become readily apparent to those skilled in this art from reading the above-recited detailed description and drawings of certain exemplary embodiments. It should be understood that numerous variations, modifications, and additional embodiments are possible, and accordingly, all such variations, modifications, and embodiments are to be regarded as being within the spirit and scope of this application. For example, regardless of the content of any portion (e.g., title, field, background, summary, abstract, drawing figure, etc.) of this application, unless clearly specified to the contrary, there is no requirement for the inclusion in any claim herein or of any application claiming priority hereto of any particular described or illustrated activity or element, any particular sequence of such activities, or any particular interrelationship of such elements. Moreover, any activity can be repeated, any activity can be performed by multiple entities, and/or any element can be duplicated. Further, any activity or element can be excluded, the sequence of activities can vary, and/or the interrelationship of elements can vary. Unless clearly specified to the contrary, there is no requirement for any particular described or illustrated activity or element, any particular sequence or such activities, any particular size, speed, material, dimension or frequency, or any particularly interrelationship of such elements. Accordingly, the descriptions and drawings are to be regarded as illustrative in nature, and not as restrictive. Moreover, when any number or range is described herein, unless clearly stated otherwise, that number or range is approximate. When any range is described herein, unless clearly stated otherwise, that range includes all values therein and all sub ranges therein. Any information in any material (e.g., a United States/foreign patent, United States/foreign patent application, book, article, etc.) that has been incorporated by reference herein, is only incorporated by reference to the extent that no conflict exists between such information and the other statements and drawings set forth herein. In the event of such conflict, including a conflict that would render invalid any claim herein or seeking priority hereto, then any such conflicting information in such incorporated by reference material is specifically not incorporated by reference herein.
The present invention is a continuation application of U.S. Pat. No. 9,211,405, issued Dec. 15, 2015, which is a 371 application of PCT/US2008/057626, which claims priority to U.S. Provisional Application Ser. No. 60/919,351 filed Mar. 22, 2007, entitled “Epicardial-Cathode Catheter for Ablation Purposes and Related Method Thereof,” the disclosures of all of which are hereby incorporated by reference herein in their entireties. This application is related to PCT International Application No. Serial No. PCT/US2008/056643, filed Mar. 12, 2008, entitled, “Access Needle Pressure Sensor Device and Method of Use,” which claims benefit of priority from U.S. Provisional Application Ser. No. 60/918,782, filed Mar. 19, 2007, entitled “Manometrically Monitored Introducer Needle and Method of Use;” the disclosures of which are hereby incorporated by reference herein in their entireties. This application is related to PCT International Application No. Ser. No. PCT/US2008/056816, filed Mar. 13, 2008, entitled, “Epicardial Ablation Catheter and Method of Use,” which claims benefit of priority from U.S. Provisional Application Ser. No. 60/906,689, filed Mar. 13, 2007, entitled “Epicardial Ablation Catheter and Access Sheath and Method of Use;” the disclosures of which are hereby incorporated by reference herein in their entireties.
Number | Name | Date | Kind |
---|---|---|---|
3794026 | Jacobs | Feb 1974 | A |
3814104 | Irnich | Jun 1974 | A |
4349023 | Gross | Sep 1982 | A |
4607644 | Pohndorf | Aug 1986 | A |
4817634 | Holleman et al. | Apr 1989 | A |
4935008 | Lewis, Jr. | Jun 1990 | A |
4971070 | Holleman et al. | Nov 1990 | A |
4991603 | Cohen et al. | Feb 1991 | A |
5033477 | Chin et al. | Jul 1991 | A |
5071428 | Chin et al. | Dec 1991 | A |
5158097 | Christlieb | Oct 1992 | A |
5213570 | VanDeripe | May 1993 | A |
5269326 | Verrier | Dec 1993 | A |
5300110 | Latterell et al. | Apr 1994 | A |
5335313 | Douglas | Aug 1994 | A |
5336252 | Cohen | Aug 1994 | A |
5395349 | Quiachon et al. | Mar 1995 | A |
5465711 | Moll et al. | Nov 1995 | A |
5484423 | Waskonig et al. | Jan 1996 | A |
5500012 | Brucker | Mar 1996 | A |
5509924 | Paspa et al. | Apr 1996 | A |
5544654 | Murphy et al. | Aug 1996 | A |
5662647 | Crow et al. | Sep 1997 | A |
5669882 | Pyles | Sep 1997 | A |
5702438 | Avitall | Dec 1997 | A |
5725504 | Collins | Mar 1998 | A |
5733280 | Avitall | Mar 1998 | A |
5779699 | Lipson | Jul 1998 | A |
5792217 | Camps et al. | Aug 1998 | A |
5797870 | March et al. | Aug 1998 | A |
5800428 | Nelson et al. | Sep 1998 | A |
5807249 | Qin et al. | Sep 1998 | A |
5812978 | Nolan | Sep 1998 | A |
5827216 | Igo et al. | Oct 1998 | A |
5843048 | Gross | Dec 1998 | A |
5846239 | Swanson et al. | Dec 1998 | A |
5868741 | Chia | Feb 1999 | A |
5885217 | Gisselberg et al. | Mar 1999 | A |
5916194 | Jacobsen et al. | Jun 1999 | A |
5928191 | Houser | Jul 1999 | A |
5931810 | Grabek | Aug 1999 | A |
5970457 | Brant et al. | Oct 1999 | A |
5972013 | Schmidt | Oct 1999 | A |
6032674 | Eggers et al. | Mar 2000 | A |
6036685 | Mueller | Mar 2000 | A |
6051008 | Saadat et al. | Apr 2000 | A |
6120476 | Fung et al. | Sep 2000 | A |
6123084 | Jandak et al. | Sep 2000 | A |
6148825 | Anderson et al. | Nov 2000 | A |
6156009 | Grabek | Dec 2000 | A |
6156018 | Hassett | Dec 2000 | A |
6162195 | Igo et al. | Dec 2000 | A |
6200303 | Verrior et al. | Mar 2001 | B1 |
6200315 | Gaiser et al. | Mar 2001 | B1 |
6206004 | Schmidt et al. | Mar 2001 | B1 |
6206874 | Ubby | Mar 2001 | B1 |
6216704 | Ingle | Apr 2001 | B1 |
6231518 | Grabek | May 2001 | B1 |
6237605 | Vaska et al. | May 2001 | B1 |
6263241 | Rosborough et al. | Jul 2001 | B1 |
6266567 | Ishikawa et al. | Jul 2001 | B1 |
6270476 | Santoianni et al. | Aug 2001 | B1 |
6270484 | Yoon | Aug 2001 | B1 |
6273877 | West et al. | Aug 2001 | B1 |
6278975 | Brant et al. | Aug 2001 | B1 |
6314963 | Vaska et al. | Nov 2001 | B1 |
6322536 | Rosengart et al. | Nov 2001 | B1 |
6325776 | Anderson et al. | Dec 2001 | B1 |
6416505 | Fleischman et al. | Jul 2002 | B1 |
6423051 | Kaplan et al. | Jul 2002 | B1 |
6500130 | Kinsella et al. | Dec 2002 | B2 |
6527767 | Wang et al. | Mar 2003 | B2 |
6551289 | Higuchi et al. | Apr 2003 | B1 |
6554809 | Aves | Apr 2003 | B2 |
6558382 | Jahns et al. | May 2003 | B2 |
6569082 | Chin | May 2003 | B1 |
6579288 | Swanson et al. | Jun 2003 | B1 |
6592552 | Schmidt | Jul 2003 | B1 |
6602242 | Fung | Aug 2003 | B1 |
6613062 | Leckrone et al. | Sep 2003 | B1 |
6616676 | Bashiri et al. | Sep 2003 | B2 |
6666844 | Igo et al. | Dec 2003 | B1 |
6666861 | Grabek | Dec 2003 | B1 |
6689128 | Sliwa, Jr. et al. | Feb 2004 | B2 |
6711436 | Duhaylongsod | Mar 2004 | B1 |
6723092 | Brown et al. | Apr 2004 | B2 |
6752805 | Maguire et al. | Jun 2004 | B2 |
6771996 | Bowe et al. | Aug 2004 | B2 |
6783510 | Gibson et al. | Aug 2004 | B1 |
6786898 | Guenst | Sep 2004 | B2 |
6811544 | Schaer | Nov 2004 | B2 |
6827714 | Swanson | Dec 2004 | B2 |
6827715 | Francischelli et al. | Dec 2004 | B2 |
6835193 | Epstein et al. | Dec 2004 | B2 |
6837848 | Bonner et al. | Jan 2005 | B2 |
6837886 | Collins et al. | Jan 2005 | B2 |
6849075 | Bertolero et al. | Feb 2005 | B2 |
6868291 | Bonner et al. | Mar 2005 | B1 |
6869414 | Simpson et al. | Mar 2005 | B2 |
6876885 | Swoyer et al. | Apr 2005 | B2 |
6899710 | Hooven | May 2005 | B2 |
6916318 | Francischelli et al. | Jul 2005 | B2 |
6918890 | Schmidt | Jul 2005 | B2 |
6918908 | Bonner et al. | Jul 2005 | B2 |
6921295 | Sommer et al. | Jul 2005 | B2 |
6928313 | Peterson | Aug 2005 | B2 |
6936040 | Kramm et al. | Aug 2005 | B2 |
6960205 | Jahns et al. | Nov 2005 | B2 |
6968223 | Hanover | Nov 2005 | B2 |
6973352 | Tsutsui et al. | Dec 2005 | B1 |
6974454 | Hooven | Dec 2005 | B2 |
7004937 | Lentz et al. | Feb 2006 | B2 |
7008418 | Hall et al. | Mar 2006 | B2 |
7027876 | Casavant et al. | Apr 2006 | B2 |
7037296 | Kadziauskas et al. | May 2006 | B2 |
7041099 | Thomas et al. | May 2006 | B2 |
7048733 | Hartley et al. | May 2006 | B2 |
7059878 | Hendrixson | Jun 2006 | B1 |
7063693 | Guenst | Jun 2006 | B2 |
7085606 | Flach et al. | Aug 2006 | B2 |
7089063 | Lesh et al. | Aug 2006 | B2 |
7090637 | Danitz et al. | Aug 2006 | B2 |
7101362 | Vanney | Sep 2006 | B2 |
7104986 | Hovda et al. | Sep 2006 | B2 |
7120504 | Osypka | Oct 2006 | B2 |
7130699 | Huff et al. | Oct 2006 | B2 |
7142919 | Hine et al. | Nov 2006 | B2 |
7146225 | Guenst et al. | Dec 2006 | B2 |
7147633 | Chee et al. | Dec 2006 | B2 |
7207988 | Leckrone et al. | Apr 2007 | B2 |
7214180 | Chin | May 2007 | B2 |
7226448 | Bertolero et al. | Jun 2007 | B2 |
7226458 | Kaplan et al. | Jun 2007 | B2 |
7232422 | Gibson et al. | Jun 2007 | B2 |
7247139 | Yudkovitch et al. | Jul 2007 | B2 |
7259906 | Islam | Aug 2007 | B1 |
7264587 | Chin | Sep 2007 | B2 |
7286992 | Sander et al. | Oct 2007 | B2 |
7309328 | Kaplan et al. | Dec 2007 | B2 |
7398781 | Chin | Jul 2008 | B1 |
7468029 | Robertson, Jr. | Dec 2008 | B1 |
8048072 | Verin | Nov 2011 | B2 |
8271095 | O'Sullivan | Sep 2012 | B2 |
9211405 | Mahapatra et al. | Dec 2015 | B2 |
20010001314 | Davison et al. | May 2001 | A1 |
20010020166 | Daly et al. | Sep 2001 | A1 |
20010025178 | Mulier et al. | Sep 2001 | A1 |
20010039410 | Verrier et al. | Nov 2001 | A1 |
20010056280 | Underwood et al. | Dec 2001 | A1 |
20020002372 | Jahns et al. | Jan 2002 | A1 |
20020019626 | Sharkey et al. | Feb 2002 | A1 |
20020045895 | John, Jr. et al. | Apr 2002 | A1 |
20020055714 | Rothschild | May 2002 | A1 |
20020058925 | Kaplan et al. | May 2002 | A1 |
20020072737 | Belden et al. | Jun 2002 | A1 |
20020077600 | Sirimanne | Jun 2002 | A1 |
20020082523 | Kinsella et al. | Jun 2002 | A1 |
20020161361 | Sherman et al. | Oct 2002 | A1 |
20030028187 | Vaska et al. | Feb 2003 | A1 |
20030065318 | Pendekanti | Apr 2003 | A1 |
20030069572 | Wellman et al. | Apr 2003 | A1 |
20030114796 | Schmidt | Jun 2003 | A1 |
20030181855 | Simpson et al. | Sep 2003 | A1 |
20040024397 | Griffin, III et al. | Feb 2004 | A1 |
20040024413 | Lentz et al. | Feb 2004 | A1 |
20040024435 | Leckrone et al. | Feb 2004 | A1 |
20040034365 | Lentz et al. | Feb 2004 | A1 |
20040064138 | Grabek | Apr 2004 | A1 |
20040068312 | Sigg et al. | Apr 2004 | A1 |
20040087831 | Michels et al. | May 2004 | A1 |
20040087938 | Leckrone et al. | May 2004 | A1 |
20040102804 | Chin | May 2004 | A1 |
20040138526 | Guenst | Jul 2004 | A1 |
20040138527 | Bonner et al. | Jul 2004 | A1 |
20040138531 | Bonner et al. | Jul 2004 | A1 |
20040147826 | Peterson | Jul 2004 | A1 |
20040186507 | Hall et al. | Sep 2004 | A1 |
20040215168 | Verrier et al. | Oct 2004 | A1 |
20040216748 | Chin | Nov 2004 | A1 |
20040267303 | Guenst | Dec 2004 | A1 |
20040267326 | Ocel et al. | Dec 2004 | A1 |
20050020914 | Amundson et al. | Jan 2005 | A1 |
20050027243 | Gibson et al. | Feb 2005 | A1 |
20050085769 | MacMahon et al. | Apr 2005 | A1 |
20050096522 | Reddy et al. | May 2005 | A1 |
20050154376 | Riviere et al. | Jul 2005 | A1 |
20050234507 | Geske et al. | Oct 2005 | A1 |
20050251094 | Peterson | Nov 2005 | A1 |
20050256368 | Klenk et al. | Nov 2005 | A1 |
20050261673 | Bonner et al. | Nov 2005 | A1 |
20050273006 | Stewart et al. | Dec 2005 | A1 |
20050273144 | Lennox | Dec 2005 | A1 |
20060025705 | Whittaker et al. | Feb 2006 | A1 |
20060025762 | Mohan et al. | Feb 2006 | A1 |
20060041243 | Nayak et al. | Feb 2006 | A1 |
20060052660 | Chin | Mar 2006 | A1 |
20060064056 | Coyle et al. | Mar 2006 | A1 |
20060064058 | Coyle | Mar 2006 | A1 |
20060074397 | Shimada | Apr 2006 | A1 |
20060106442 | Richardson et al. | May 2006 | A1 |
20060122591 | Keidar | Jun 2006 | A1 |
20060189840 | Walsh et al. | Aug 2006 | A1 |
20060200002 | Guenst | Sep 2006 | A1 |
20060229490 | Chin | Oct 2006 | A1 |
20060247522 | McGee | Nov 2006 | A1 |
20060247672 | Vidlund et al. | Nov 2006 | A1 |
20060259017 | Heil, Jr. et al. | Nov 2006 | A1 |
20060270900 | Chin et al. | Nov 2006 | A1 |
20060271032 | Chin et al. | Nov 2006 | A1 |
20070016068 | Grunwald et al. | Jan 2007 | A1 |
20070016069 | Grunwald et al. | Jan 2007 | A1 |
20070016070 | Grunwald et al. | Jan 2007 | A1 |
20070016072 | Grunwald et al. | Jan 2007 | A1 |
20070032796 | Chin-Chen et al. | Feb 2007 | A1 |
20070038052 | Swoyer et al. | Feb 2007 | A1 |
20070043397 | Ocel et al. | Feb 2007 | A1 |
20070055142 | Webler | Mar 2007 | A1 |
20070198041 | Rupp et al. | Aug 2007 | A1 |
20070270882 | Hjelle et al. | Nov 2007 | A1 |
20080015625 | Ventura et al. | Jan 2008 | A1 |
20080051671 | Broome et al. | Feb 2008 | A1 |
20080091109 | Abraham | Apr 2008 | A1 |
20080097399 | Sachar et al. | Apr 2008 | A1 |
20080108945 | Kaplan et al. | May 2008 | A1 |
20080183080 | Abraham | Jul 2008 | A1 |
20080208184 | Davies | Aug 2008 | A1 |
20080262432 | Miller | Oct 2008 | A1 |
20080294174 | Bardsley et al. | Nov 2008 | A1 |
20090030469 | Meiry | Jan 2009 | A1 |
20100069849 | Kassab | Mar 2010 | A1 |
20100094143 | Mahapatra et al. | Apr 2010 | A1 |
20100114093 | Mahapatra et al. | May 2010 | A1 |
20100211064 | Mahapatra et al. | Aug 2010 | A1 |
20100241185 | Mahapatra et al. | Sep 2010 | A1 |
Number | Date | Country |
---|---|---|
7052296 | Jan 1997 | AU |
2236958 | Nov 1998 | CA |
4313903 | Sep 1994 | DE |
0134367 | Mar 1985 | EP |
0450608 | Oct 1991 | EP |
1129681 | Sep 2001 | EP |
1181896 | Feb 2002 | EP |
2279773 | Feb 2011 | EP |
8704081 | Jul 1987 | WO |
9320878 | Oct 1993 | WO |
9320886 | Oct 1993 | WO |
9510319 | Apr 1995 | WO |
9515115 | Jun 1995 | WO |
9733526 | Sep 1997 | WO |
WO 9800060 | Jan 1998 | WO |
9918869 | Apr 1999 | WO |
0105306 | Jan 2001 | WO |
0158373 | Aug 2001 | WO |
0168173 | Sep 2001 | WO |
0180724 | Nov 2001 | WO |
0180757 | Nov 2001 | WO |
WO 03092792 | Nov 2003 | WO |
2008112870 | Sep 2008 | WO |
2008115745 | Sep 2008 | WO |
2008118737 | Oct 2008 | WO |
2009062061 | May 2009 | WO |
Entry |
---|
U.S. Appl. No. 12/530,938, Final Office Action dated Sep. 30, 2015, 24 pages. |
U.S. Appl. No. 12/530,938, Final Office Action dated Nov. 21, 2013, 30 pages. |
U.S. Appl. No. 12/530,938, Non-Final Office Action dated Dec. 4, 2014, 21 pages. |
U.S. Appl. No. 12/530,938, Non-Final Office Action dated Jun. 25, 2012, 48 pages. |
U.S. Appl. No. 12/530,938, Non-Final Office Action dated Feb. 26, 2013, 32 pages. |
U.S. Appl. No. 12/532,233, Final Office Action dated May 15, 2013, 22 pages. |
U.S. Appl. No. 12/532,233, Non-Final Office Action dated Aug. 7, 2014, 14 pages. |
U.S. Appl. No. 12/532,233, Notice of Allowance dated Aug. 14, 2015, 5 pages. |
U.S. Appl. No. 12/532,233, Notice of Allowance dated Apr. 2, 2015, 7 pages. |
U.S. Appl. No. 12/532,233, Non-Final Office Action dated Oct. 26, 2012, 18 pages. |
U.S. Appl. No. 12/532,233, Non-Final Office Action dated Mar. 7, 2012, 53 pages. |
U.S. Appl. No. 12/741,710, Final Office Action dated Jun. 15, 2015, 16 pages. |
U.S. Appl. No. 12/741,710, Final Office Action dated Apr. 22, 2014, 24 pages. |
U.S. Appl. No. 12/741,710, Non-Final Office Action dated Jul. 3, 2013, 14 pages. |
U.S. Appl. No. 12/741,710, Office Action dated Nov. 8, 2012, 54 pages. |
European Patent Application No. 10846297.9, Office Action dated Jul. 1, 2014, 5 pages. |
Arrow International Corporation, AN-05505 Epidural Needle, Available online at vvww.arrowintl.com/products/boms/AN05505.asp?cat=17&item=AN-05505&xsec=. |
Beukema, Radiofrequency Ablation of Atrial Fibrillation in Patients Undergoing Concommitant Cardiac Surgery. First Experience, Pace, vol. 20, Part 2, 1997, pp. 1100. |
D'Avila, “Transthoracic Epicardial Catheter Ablation of Ventricular Tachycardia,” Heart Rhythmn, 2006, p. 1110-1111, vol. 3. |
Derose, Robotically Assisted Left Ventricular Epicardial Lead Implantation for Biventricular Pacing: the Posterior Approach, The Annals of Thoracic Surgery, vol. 77, 2004, pp. 1472-1474. |
Frolich, Pioneers in Epidural Needle Design, Anesthesia & Analgesia, vol. 93, 2001, pp. 215-220. |
Hansky, Lead Selection and Implantation Technique for Biventricular Pacing, European Heart Journal Supplements, vol. 6, Supplement D, 2004, pp. D112-D116. |
Klein, Radiofrequency Ablation of Cardiac Arrhythmias, Scientific American Science & Medicine, 1994, pp. 48-57. |
Lin, Catheter Microwave Ablation Therapy for Cardiac Arrhythmias, Bioelectromagnetics, vol. 20, 1999, pp. 120-132. |
Mahapatra, Access Device and Manometric Monitoring System for Epicardial Electrophysiology: Improved Porototype and Use in Human Trials, Technical Report No. UVA/640419/MAE08/102, Jan. 2008. |
Mahapatra, Access Device and Manometric Monitoring System for Epicardial Electrophysiology: Improved Porototype and Use in Human Trials, Technical Report No. UVA/640419/MAE08/101, Jul. 2007. |
Mahapatra, Incidence and Predictors of Cardiac Perforation after Permanent Pacemaker Placement, Heart Rhythm, vol. 2, No. 9, 2005, pp. 907-911. |
Mair, Epicardial Lead Implantation Techniques for Biventricular Pacing via Left Lateral Mini-Thoracotomy, Video-Assisted Thoracoscopy, and Robotic Approach, the Heart Surgery Forum #2003-4883, vol. 6, No. 5, 2003, pp. 412-417. |
Moses, Sirolimus-Eluting Stents Versus Standard Stents in Patients with Stenosis in a Native Coronary Artery, New England Journal of Medicine, vol. 349, No. 14, 2003, pp. 1315-1323. |
Omega Engineering Inc., DP25B-S Strain Gage Pagel Meter: User's Guide, Stamford, CT. Online available at http://vvww.omega.com/Manuals/manualpdf/M3598.pdf, 2002, 68 pages. |
Omega Engineering Inc., DPI 603 Portable Pressure Calibrator User Guide, Stamford, CT. Available online at http://www.omega.com/Manuals/manual.pdf/M2913.pdf, 1996, 41 pages. |
Omega Engineering Inc., PX26 Series Pressure Transducers: Instruction Sheet, Stamford, CT. Available online at http://vvww.omega.com/Manuals/manualpdf/M1608.pdf, 2004, 2 pages. |
Omega Engineering, Inc., DP41B Universal Input Meter: User's Guide, Stamford, CT. Available online at http://www.omega.com/Manuals/manualpdf.M2544.pdf, 2005, 132 pages. |
Omega Engineering, Inc., PX26 Series Pressure Transducers: Instruction Sheet, Stamford, CT. Available online at http//www.omega.com/Pressure/pdf/PX26.pdf, 2004, 1 page. |
Packer, Multimodality 3-D Ultrasound and Computed Tomographic Image Fusion: A Novel Basis for Catheter Navigation and Electroanatomic Mapping, Circulation, Clinical Science, vol. 112, No. 17, Supplement 11, #2939, 2005. |
Sarabanda, Efficacy and Safety of Circumferential Pulmonary Vein Isolation Using a Novel Cryothermal Balloon Ablation System, Journal of the American College of Cardiology, vol. 46, No. 10, 2005, pp. 1902-1912. |
Sosa, Epicardial Mapping and Ablation Techniques to Control Ventricular Tachycardia, Journal of Cardiovascular Electrophysiology, vol. 16, No. 4, 2005, pp. 449-452. |
Sosa, Nonsurgical Transthoracic Epicardial Approach in Patients with Ventricular Tachycardia and Previous Cardiac Surgery, Journal of Interventional Cardiac Electrophysiology, vol. 10, 2004, pp. 281-288. |
Sosa, Percutaneous Pericardia! Access for Mapping and Ablation of Epicardial Ventricular Tachycardias, Circulation, Journal of the American Heart Association, vol. 115, 2007, pp. e542-e544. |
Sosa, Transthoracic Epicardial Catheter Ablation of Ventricular Tachycardia, Heart Rhythm, vol. 3, 2006, pp. 1110-1111. |
Stokes, U.S. Statutory Invention Registration H356, Nov. 3, 1987. |
Thomas, Analysis of Human Epidural Pressures, Regional Anesthesia, vol. 17, No. 4, 1992, pp. 212-215. |
Tomaske, Do Daily Threshold Trend Fluctuations of Epicardial Leads Correlate with Pacing and Sensing Characteristics in Paediatric Patients, Europace, vol. 9, 2007, pp. 662-668. |
Aupperle et al., “Ablation of Atrial Fibrillation and Esophageal Injury: Effects of Energy Source and Ablation Technique,” Journal of Thoracic and Cardiovascular Surgery, vol. 130, No. 6, pp. 1549-1554, (2005). |
IPRP with Written Opinion and International Search Report corresponding to International Patent Application No. PCT/US2008/057626 dated Sep. 22, 2009. |
Scanavacca et al., “Catheter Ablation of Atrial Fibrillation. Techniques and Results,” Arquivos Brasileiros de Cardiologia, vol. 85, No. 4, 7 pps., (2005). |
Tungjitkusolmun et al., “Finite Element Analyses of Uniform Curren Density Electrodes for Raio-Frequency Cardiac Ablation,” IEEE Transactions on Biomedical Engineering, vol. 47, No. 1, pp. 32-40, (2000). |
Müller et al., “Application of CVD-diamond for catheter ablation in the heart,” Diamond and Related Materials, vol. 13, pp. 1080-1083 (2004). |
Petersen et al., “Mechanisms for Enlarging Lesion Size During Irrigated Tip Radiofrequency Ablation: Is There a Virtual Electrode Effect?” Journal of Interventional Cardiology, vol. 17, No. 3, pp. 171-177 (2004). |
Schwartzman et al., “Catheter Ablation of Ventricular Tachycardia Associated with Remote Myocardial Infaction: Utility of the Atrial Transseptal Approach,” Journal of Interventional Cardiac Electrophysiology, vol. 1, pp. 67-71 (1997). |
Number | Date | Country | |
---|---|---|---|
20160331445 A1 | Nov 2016 | US |
Number | Date | Country | |
---|---|---|---|
60919351 | Mar 2007 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12532233 | US | |
Child | 14967923 | US |